| Literature DB >> 31602258 |
Shu-Hui Lin1,2, Mu-Kuan Chen3, Julia Hueimei Chang1, Bharath Kumar Velmurugan4, Madhavi Annamanedi5, Shih-Chi Su6, Kun-Tu Yeh1,7, Shun-Fa Yang8,9.
Abstract
In Taiwan, the incidence rate of oral cancer is constantly increasing. Polymorphisms and lifestyle habits are major contributing factors to the development of oral cancer in such cases. Casein kinase 1 epsilon (CK1ε) gene expression plays a role in numerous cancers, and the knockdown of CK1ε induces tumor cell-selective cytotoxicity. The present study was designed to determine the effects of CK1ε gene polymorphisms combined with environmental carcinogens on susceptibility to developing oral squamous cell carcinoma and its clinicopathological status. Four single-nucleotide polymorphisms (SNPs) in CK1ε gene (rs135745, rs135764, rs1997644 and rs2075984) from 741 oral cancer patients and 462 healthy controls were analyzed using real-time polymerase chain reaction. Our results shown that variant types (GC) of CK1ε polymorphic rs135745 exhibited a significantly higher risk of 1.41 (95% confidence interval [CI]: 1.036-1.919) for oral cancer than did wild type alleles. Furthermore, these CK1ε gene SNPs along with betel-quid chewing and/or tobacco use further increased susceptibility to oral cancer. Moreover, variant genotypes (GC+CC) of CK1ε rs135745 were significantly associated with lymph node metastasis. These results suggested that the CK1ε gene polymorphism is associated with the clinicopathological development of oral cancer and increases individuals' susceptibility to environmental carcinogens (e.g., smoking and betel-quid chewing) in terms of developing oral cancer. © The author(s).Entities:
Keywords: Casein kinase 1 epsilon; oral cancer; polymorphism
Year: 2019 PMID: 31602258 PMCID: PMC6775616 DOI: 10.7150/jca.34592
Source DB: PubMed Journal: J Cancer ISSN: 1837-9664 Impact factor: 4.207
Distributions of demographical characteristics in 462 controls and 741 male patients with oral cancer.
| Variable | Controls ( | Patients ( | |
|---|---|---|---|
| 47.5 ± 13.88 | 54.5 ± 11.13 | ||
| No | 375 (81.2%) | 158 (21.3%) | |
| Yes | 87 (18.8%) | 583 (78.7%) | |
| No | 275 (59.5%) | 107 (14.4%) | |
| Yes | 187 (40.5%) | 634 (85.6%) | |
| No | 309 (66.9%) | 320 (43.2%) | |
| Yes | 153 (33.1%) | 421 (56.8%) | |
| I+II | 349 (47.1%) | ||
| III+IV | 392 (52.9%) | ||
| T1+T2 | 408 (55.1%) | ||
| T3+T4 | 333 (44.9%) | ||
| N0 | 492 (66.4%) | ||
| N1+N2+N3 | 249 (33.6%) | ||
| M0 | 732 (98.8%) | ||
| M1 | 9 (1.2%) | ||
| Well differentiated | 113 (15.2%) | ||
| Moderately or poorly differentiated | 628 (84.8%) |
The Mann-Whitney U-test or Fisher's exact test was used between healthy controls and patients with oral cancer. * p<0.05.
The odds ratio (OR), adjusted OR (AOR), and 95% confidence interval (CI) of oral cancer associated with CK1 epsilon genotypic frequencies
| Variable | Controls ( | Patients ( | OR (95% CI) | AOR (95% CI)a |
|---|---|---|---|---|
| GG | 341 (73.8%) | 497 (67.1%) | Reference | Reference |
| GC | 111 (24.0%) | 229 (30.9%) | 1.39 (1.052-1.834)* | 1.41 (1.036-1.919)* |
| CC | 10 (2.2%) | 15 (2.0%) | 0.95 (0.417-2.171) | 0.85 (0.331-2.197) |
| GC+CC | 121 (26.2%) | 243 (32.8%) | 1.32 (1.010-1.724)* | 1.34 (0.992-1.799) |
| GG | 331 (71.6%) | 532 (71.8%) | Reference | Reference |
| GA | 123 (26.6%) | 190 (25.6%) | 0.93 (0.679-1.278) | 0.98 (0.692-1.400) |
| AA | 8 (1.7%) | 19 (2.6%) | 1.45 (0.577-3.665) | 1.80 (0.671-4.832) |
| GA+AA | 131 (28.3%) | 209 (28.2%) | 0.94 (0.698-1.274) | 1.03 (0.739-1.444) |
| GG | 187 (40.5%) | 322 (43.5%) | Reference | Reference |
| GA | 221 (47.8%) | 327(44.1%) | 0.84 (0.652-1.083) | 0.85 (0.640-1.130) |
| AA | 54 (11.7%) | 92 (12.4%) | 1.02 (0.689-1.520) | 0.90 (0.574-1.398) |
| GA+AA | 275 (59.5%) | 419 (56.5%) | 0.88 (0.691-1.118) | 0.87 (0.664-1.137) |
| AA | 159 (34.4%) | 246 (33.2%) | Reference | Reference |
| AC | 221 (47.8%) | 371 (50.1%) | 1.19 (0.880-1.621) | 1.13 (0.802-1.580) |
| CC | 82 (17.8%) | 124 (16.7%) | 0.98 (0.694-1.377) | 1.13 (0.676-1.885) |
| AC+CC | 303 (65.6%) | 495 (66.8%) | 1.17(0.864-1.579) | 1.13 (0.805-1.573) |
The OR with its 95% CI was estimated by logistic regression models.
The AOR with its 95% CI was estimated by multiple logistic regression models after controlling for age, betel quid chewing, cigarette smoking, and alcohol consumption.
* p<0.05.
Associations of the combined effect of CK1 epsilon gene polymorphisms and betel nut chewing with the susceptibility to oral cancer among 821 smokers.
| Variable | Controls (N=187) (%) | Patients (N=634) (%) | OR (95% CI) | AOR (95% CI) |
|---|---|---|---|---|
| GG genotype and non betel-nut chewing | 87 (46.5%) | 58 (9.1%) | Reference | Reference |
| GC or CC genotype or betel-nut chewing | 87 (46.5%) | 393 (62.0%) | 6.776 (4.518-10.163) | 6.150 (4.069-9.296) |
| GC or CC genotype with betel-nut chewing | 13 (7.0%) | 183 (28.9%) | 21.115 (10.986-40.583) | 19.031 (9.840-36.807) |
| GG genotype and non betel-nut chewing | 84 (44.9%) | 60 (9.5%) | Reference | Reference |
| GA or AA genotype or betel-nut chewing | 80 (42.8%) | 422 (66.6%) | 7.385 (4.908-11.111) | 6.988 (4.597-10.621) |
| GA or AA genotype with betel-nut chewing | 23 (12.3%) | 152 (24.0%) | 9.252 (5.340-16.030) | 9.196 (5.250-16.108) |
| GG genotype and non betel-nut chewing | 47 (25.1%) | 31 (4.9%) | Reference | Reference |
| GA or AA genotype or betel-nut chewing | 96 (51.3%) | 287 (45.3%) | 4.533 (2.725-7.540) | 4.366 (2.586-7.369) |
| GA or AA genotype with betel-nut chewing | 44 (23.5%) | 316 (49.8%) | 10889 (6.267-18.917) | 10.572 (6.001-18.627) |
| AA genotype and non betel-nut chewing | 42 (22.5%) | 32 (5.0%) | Reference | Reference |
| AC or CC genotype or betel-nut chewing | 99 (52.9%) | 238 (37.5%) | 3.155 (0.1883-5.287) | 2.990 (1.759-5.080) |
| AC or CC genotype with betel-nut chewing | 46 (24.6%) | 364 (57.4%) | 10.386 (5.975-18.052) | 9.476 (5.383-16.681) |
The adjusted odds ratio (OR; AOR) with its 95% confidence interval (CI) was estimated by multiple logistic regression models after controlling for age and alcohol consumption.
Distribution frequency of clinical status and CK1 epsilon rs135745 genotype frequencies in 741 patients with oral cancer.
| Variable | GG (N = 497) | GC + CC (N = 244) | OR (95% CI) | AOR (95% CI) |
|---|---|---|---|---|
| I/II | 238 (47.9%) | 111 (45.5%) | Reference | Reference |
| III//IV | 259 (52.1%) | 133 (54.5%) | 0.795 (0.480-1.629) | 0.796 (0.481-1.319) |
| T1/T2 | 274 (55.1%) | 134 (54.9%) | Reference | Reference |
| T3/T4 | 223 (44.9%) | 110 (45.1%) | 1.082 (0.732-1.600) | 1.081 (0.731-1.598) |
| No | 342 (68.8%) | 150 (61.5%) | Reference | Reference |
| Yes | 155 (31.2%) | 94 (38.5%) | 1.623 (1.038-2.537)* | 1.622 (1.037-2.536)* |
| No | 490 (98.6%) | 242 (99.2%) | Reference | Reference |
| Yes | 7 (1.4%) | 2 (0.8%) | 0.458 (0.093-2.259) | 0.461 (0.093-2.277) |
| Well | 78 (15.7%) | 35 (14.3%) | Reference | Reference |
| Moderate/Poor | 419 (84.3%) | 209 (85.7%) | 1.052(0.679-1.629) | 1.055 (0.995-1.007) |
The OR with its 95% CI was estimated by logistic regression models.
The AOR with its 95% CI was estimated by multiple logistic regression models after controlling for age, betel quid chewing, cigarette smoking, and alcohol consumption.
* p<0.05.